Answers are grounded in this paper and cite their sources.
Targeted treatment is a therapy directed at a specific molecular target close to a hallmark of cancer. The target should be measurable with a biomarker and measurement of the target should correlate with clinical outcome when targeted treatment is administered. Current clinical guidelines do not recommend targeted or biological therapy in MPM. However, since these recommendations came out, new agents have been investigated in MPM. This review updates the use of targeted and biological treatment in patients with mesothelioma.
No takes yet. Share an insight, caveat, or question.
Hiddinga et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: